Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different doses of letrozole plus urofollitropin for ovulation induction in PCOS (pRCT)
ChiCTR2300069638Phase 4Not yet recruiting
- Sponsor
- Union Hospital
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of letrozole and urofollitropin in polycystic ovary syndrome (PCOS) and anovulatory infertility (2 arms), sponsored by Union Hospital. Primary endpoints: Ovulation rate, Pregnancy rate and 2 more. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
letrozoleurofollitropin
03
Conditions
polycystic ovary syndrome (PCOS)anovulatory infertility
Beyond the preview
Go deeper on ChiCTR2300069638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069638.